# Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

> **NCT01634152** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 401 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo
- **DRUG:** Tiotropium low dose mcg
- **DRUG:** Tiotropium high dose

## Key facts

- **NCT ID:** NCT01634152
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2016-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01634152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01634152, "Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01634152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*